A diagnosis of high-grade endometrioid adenocarcinoma with YST differentiation was rendered based on the morphologic features and immunopositivity for SALL-4, glypican-3, and AFP (Figure 2). This evidence concerns the gene GPC3 and endometrioid adenocarcinoma.